Diversity of Y region at HML locus in a Saccharomyces cerevisiae strain isolated from a Sardinian wine.

Antonie Van Leeuwenhoek

Dipartimento di Scienze Ambientali Agrarie e Biotecnologie Agro-Alimentari (DiSAABA), Sezione di Microbiologia Generale ed Applicata, Università di Sassari, Viale Italia 39, 07100 Sassari, Italy.

Published: January 2004

Several mutations in genes involved in Saccharomyces mating type switching may affect the homothallic behaviour in wine yeasts. In this study the semi-homothallic (Hq) segregation of a flor wine yeast strain was analysed. We aimed to understand the molecular basis of this behaviour in a flor autochthonous strain, verifying the MAT locus status by a PCR-based HO gene disruption and sequencing of the Y region of the HML, HMR and MAT loci, after nested PCR. Presence of ORFs a1 and a2 in the Y region of the HML locus was found. At the ORF a2 at HML locus, a mutation in the stop codon was found, so the a2 ORF contains 33 more bases.

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:ANTO.0000020269.80900.45DOI Listing

Publication Analysis

Top Keywords

region hml
12
hml locus
12
diversity region
4
hml
4
locus
4
locus saccharomyces
4
saccharomyces cerevisiae
4
cerevisiae strain
4
strain isolated
4
isolated sardinian
4

Similar Publications

Background: This study delves into the complex interplay between genetics, 25-hydroxyvitamin D (25OHD), and schizophrenia (SCZ). It leverages extensive sample data derived from Genome-Wide Association Studies (GWAS) to uncover genetic correlations.

Methods: Employing Linkage Disequilibrium Score Regression (LDSC) and S-LDSC, this study investigates genetic connections between 25OHD and SCZ.

View Article and Find Full Text PDF
Article Synopsis
  • Age-related macular degeneration (AMD) is a common cause of vision loss among older adults, and current treatment options are limited.
  • Researchers identified genetic factors contributing to AMD risk by analyzing data from 12,495 AMD cases and 461,686 controls, discovering four key protective haplotypes.
  • The study suggests that lowering levels of the protein FHR-5 could enhance certain immune pathways and potentially serve as a strategy to prevent or treat AMD.
View Article and Find Full Text PDF

DNA Hypomethylation Is One of the Epigenetic Mechanisms Involved in Salt-Stress Priming in Soybean Seedlings.

Plant Cell Environ

November 2024

Centre for Soybean Research of the State Key Laboratory of Agrobiotechnology and School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.

Article Synopsis
  • *This process involves global DNA hypomethylation and alterations in histone modifications, which impact gene regulation.
  • *A DNA methyltransferase inhibitor can mimic the benefits of priming, indicating that reducing DNA methylation enhances salt tolerance in non-primed seedlings.
View Article and Find Full Text PDF

Aims/hypothesis: Type 2 diabetes is a complex and heterogeneous disease and the aetiological components underlying the heterogeneity remain unclear in the Chinese and East Asian population. Therefore, we aimed to investigate whether specific pathophysiological pathways drive the clinical heterogeneity in type 2 diabetes.

Methods: We employed newly developed type 2 diabetes hard-clustering and soft-clustering pathway-specific polygenic risk scores (psPRSs) to characterise individual genetic susceptibility to pathophysiological pathways implicated in type 2 diabetes in 18,217 Chinese patients from Hong Kong.

View Article and Find Full Text PDF

Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma.

Sci Rep

November 2024

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.

In this multi-center, Phase-1 study (NCT03733717), we characterized the pharmacokinetics (PK) of the anti-CD38 antibody isatuximab (Isa) after IV administration (primary objective), and evaluated safety, immunogenicity, and preliminary anti-myeloma activity in Chinese patients with relapsed/refractory multiple myeloma (RRMM). Isa 20-mg/kg was administered weekly (QW) in cycle 1, then biweekly (Q2W). Twenty-one extensively pretreated RRMM patients (median 4 prior lines; 95.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!